Please login to the form below

Not currently logged in
Email:
Password:

Eperzan

This page shows the latest Eperzan news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk's oral GLP-1 analogue looks set for phase III

Novo Nordisk's oral GLP-1 analogue looks set for phase III

If the injectable version is approved it will have to compete with a number of similar products on the market - notably AstraZeneca's Bydureon (exenatide), GlaxoSmithKline's Tanzeum/Eperzan (albiglutide) and

Latest news

  • FDA approves Lilly’s GLP-1 diabetes drug Trulicity FDA approves Lilly’s GLP-1 diabetes drug Trulicity

    Competition is heating up, however, and GlaxoSmithKline has won approval for once-weekly albiglutide in the US under the name Tanzeum and in the EU under the name Eperzan.

  • GSK gets OK in US for diabetes drug albiglutide GSK gets OK in US for diabetes drug albiglutide

    Albiglutide - which will be sold in Europe as Eperzan - has been approved for improving glycaemic control along with diet and exercise, and can be used alone or in combination with other

  • EMA clears GSK's diabetes therapy Eperzan EMA clears GSK's diabetes therapy Eperzan

    Once-weekly GLP-1 therapy will line-up against Victoza and Byetta.  . GlaxoSmithKline says it will launch its once-weekly diabetes therapy Eperzan in the EU later this year after winning ... Eperzan (albiglutide) has been approved to improve glucose

  • GSK's diabetes drug among CHMP recommendations GSK's diabetes drug among CHMP recommendations

    GlaxoSmithKline's (GSK) new diabetes drug Eperzan was among four new pharma products recommended for approval at the end of last week by the European Medicines Agency (EMA). ... Eperzan (albiglutide) stood out among the recommendations as it is GSK's

  • GSK submits albiglutide for European approval GSK submits albiglutide for European approval

    If approved the diabetes drug will be launched as Eperzan. GlaxoSmithKline (GSK) has submitted its albiglutide once-weekly injection for type 2 diabetes to European regulators. ... If approved the biologic treatment, which was submitted for US approval

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics